You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Chemotherapy

The guidelines and other documents available here provide recommendations on safe and effective chemotherapy for people with cancer in Ontario.

Displaying Guidelines

138 articles

2019 Antiemetic Recommendations for Chemotherapy-Induced Nausea and Vomiting: A Clinical Practice Guideline

Document Status: Current
ID: GL-C50-09

Jun 2019

Adjuvant Care for Stage I Ovarian Cancer

Document Status: Current
ID: 4-13
Version: 3

Mar 2022

Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adults

Document Status: Archived
ID: 11-2
Version: 2

Oct 2014

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer

Document Status: Archived
ID: 1-9

Jun 2010

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Document Status: Current
ID: 2-29
Version: 4

Updated

Feb 2024

Adjuvant Systemic Chemotherapy, Following Surgery and External Beam Radiotherapy, for Adults with Newly Diagnosed Malignant Glioma

Document Status: Archived
ID: 9-2

Nov 2013

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Document Status: Current
ID: GL-7-A-2016-3

Apr 2017

Adjuvant Systemic Therapy for Node-negative Breast Cancer

Document Status: Archived
ID: 1-8

Sep 2011

Adjuvant Taxane Therapy for Women with Early-stage, Invasive Breast Cancer

Document Status: Archived
ID: 1-7
Version: 2

Sep 2011

Adult Acute Leukemia Services Plan for the Greater Toronto Area - Recommendations Report

Document Status: Current
ID: GL-C50-02

Jan 2012

Alemtuzumab in Chronic Lymphocytic Leukemia

Document Status: Education and Information
ID: 6-16 Version 2
Version: 2

Feb 2014

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Updated

Mar 2024